Moderna stock surges as melanoma vaccine trial shows "landmark moment"
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
Watch CBS News
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
The new COVID-19 vaccine from Moderna, mNexspike, is made in a way that allows for a lower dose.
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.
Moderna's stock soared after the COVID-19 vaccine maker detailed progress in developing a potential preventive shot for melanoma, a deadly form of skin cancer.
Recent small studies, not yet peer-reviewed, suggested the new boosters may not be significantly better than the original vaccine formula.
The new shots are rolling out to pharmacies and other vaccination sites around the country.
The first shots in the Biden administration's fall booster campaign could start in days, after a vote by the CDC's advisers.
It's likely everyone will need a booster shot within 12 months of getting a COVID vaccination, but should you get your booster from the same company that made your original vaccine? Dr. Dave Hnida has the answer.
Coloradans are now receiving doses of both of the vaccines which have received emergency use authorization from the FDA. CBS4 Medical Editor Dr. Dave Hnida took time to explain some of the differences on CBSN Denver.
Health officials expect 95,600 doses of the Moderna vaccine to be available.
Denver police officers are among the 217 participants of the Moderna coronavirus vaccine trial at UCHealth.
Both participants and doctors at UCHealth in Colorado are optimistic about the results of the Moderna coronavirus vaccine.
A second coronavirus vaccine in the U.S., that was tested on Colorado volunteers, is proving to be highly effective in the trials.
